Kangji Medical co-led a $92.6m round for the Legend Holdings-backed surgical robot developer that also featured China Poly Group.

Edge Medical Robotics, a China-based surgical robot developer has raised almost RMB600m ($92.6m) in a series B round co-led by surgical equipment manufacturer Kangji Medical, DealStreetAsia reported yesterday.

Life sciences investment firm Lyfe Capital, private equity fund 3H Health Investment and venture capital firm Panorama Capital co-led the round, which included Poly Capital, a subsidiary of conglomerate China Poly Group, as well as Vertex Ventures China, BioTrack Capital and Alwin Capital.

Founded in 2017, Edge has designed and developed surgical…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?